Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.84 USD
−19.92 M USD
6.21 M USD
19.43 M
About InspireMD Inc.
Sector
Industry
CEO
Marvin L. Slosman
Website
Headquarters
Miami
Founded
2005
FIGI
BBG000QDM9D4
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NSPR is 2.59 USD — it has decreased by −2.27% in the past 24 hours. Watch InspireMD Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange InspireMD Inc. stocks are traded under the ticker NSPR.
NSPR stock has fallen by −0.77% compared to the previous week, the month change is a 3.20% rise, over the last year InspireMD Inc. has showed a 1.57% increase.
We've gathered analysts' opinions on InspireMD Inc. future price: according to them, NSPR price has a max estimate of 4.50 USD and a min estimate of 4.50 USD. Watch NSPR chart and read a more detailed InspireMD Inc. stock forecast: see what analysts think of InspireMD Inc. and suggest that you do with its stocks.
NSPR reached its all-time high on Jun 1, 2011 with the price of 75,862,496.00 USD, and its all-time low was 0.81 USD and was reached on Nov 10, 2022. View more price dynamics on NSPR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NSPR stock is 2.71% volatile and has beta coefficient of −0.46. Track InspireMD Inc. stock price on the chart and check out the list of the most volatile stocks — is InspireMD Inc. there?
Today InspireMD Inc. has the market capitalization of 67.30 M, it has increased by 1.98% over the last week.
Yes, you can track InspireMD Inc. financials in yearly and quarterly reports right on TradingView.
InspireMD Inc. is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
NSPR earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.20 USD resulting in a 20.00% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about InspireMD Inc. earnings.
InspireMD Inc. revenue for the last quarter amounts to 1.81 M USD, despite the estimated figure of 1.74 M USD. In the next quarter, revenue is expected to reach 1.83 M USD.
NSPR net income for the last quarter is −7.89 M USD, while the quarter before that showed −7.91 M USD of net income which accounts for 0.24% change. Track more InspireMD Inc. financial stats to get the full picture.
No, NSPR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 66.00 employees. See our rating of the largest employees — is InspireMD Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. InspireMD Inc. EBITDA is −29.68 M USD, and current EBITDA margin is −332.88%. See more stats in InspireMD Inc. financial statements.
Like other stocks, NSPR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade InspireMD Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So InspireMD Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating InspireMD Inc. stock shows the sell signal. See more of InspireMD Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.